First Time Loading...

Fusion Antibodies PLC
LSE:FAB

Watchlist Manager
Fusion Antibodies PLC Logo
Fusion Antibodies PLC
LSE:FAB
Watchlist
Price: 3.75 GBX -1.32% Market Closed
Updated: Apr 25, 2024

Fusion Antibodies PLC
Capital Expenditures

Last Value
3-Years CAGR
5-Years CAGR
Quarterly
Annual
TTM
|

Fusion Antibodies PLC
Capital Expenditures Peer Comparison

Comparables:
ONT
O
ORPH
DXRX
ERGO
HVO

Competitive Capital Expenditures Analysis
Latest Figures & CAGR of Competitors

Company Capital Expenditures CAGR 3Y CAGR 5Y CAGR 10Y
Fusion Antibodies PLC
LSE:FAB
Capital Expenditures
£244k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Oxford Nanopore Technologies PLC
LSE:ONT
Capital Expenditures
-£27.3m
CAGR 3-Years
-1%
CAGR 5-Years
-9%
CAGR 10-Years
N/A
O
Open Orphan PLC
LSE:ORPH
Capital Expenditures
-£1.4m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Diaceutics PLC
LSE:DXRX
Capital Expenditures
-£4.9m
CAGR 3-Years
-18%
CAGR 5-Years
-77%
CAGR 10-Years
N/A
Ergomed PLC
LSE:ERGO
Capital Expenditures
-£2.5m
CAGR 3-Years
-37%
CAGR 5-Years
-12%
CAGR 10-Years
N/A
hVIVO PLC
LSE:HVO
Capital Expenditures
-£5.2m
CAGR 3-Years
-68%
CAGR 5-Years
-136%
CAGR 10-Years
-67%

See Also

What is Fusion Antibodies PLC's Capital Expenditures?
Capital Expenditures
244k GBP

Based on the financial report for Sep 30, 2023, Fusion Antibodies PLC's Capital Expenditures amounts to 244k GBP.